The changing landscape of mineralocorticoid receptor antagonists – finerenone in cardiovascular and renal health. Prospect. Pharm. Sci. [Internet]. 2024 Feb. 13 [cited 2026 Oct. 31];22(1):11-5. Available from: https://prospects.wum.edu.pl/index.php/pps/article/view/181